|
Jul 18
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Jul 18
|
GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning
|
|
Jul 18
|
GSK falls as blood cancer drug likely headed for US rejection
|
|
Jul 17
|
FDA Committee Votes Against GSK Blood Cancer Drug Blenrep
|
|
Jul 17
|
GSK stock falls after FDA panel rejects blood cancer drug Blenrep
|
|
Jul 17
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Jul 17
|
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation
|
|
Jul 1
|
GSK Rebranded Flovent Asthma Inhaler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses
|
|
Jun 30
|
Gilead extends gains after Supreme Court upheld an Obamacare provision
|
|
Jun 28
|
GSK (GSK) Gains FDA Approval for Benlysta Autoinjector for Lupus Treatment
|
|
Jun 27
|
Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care
|
|
Jun 26
|
Ephicacy Appoints Névine Zariffa to Its Board of Directors
|
|
Jun 25
|
Bharat, GSK to halve price of malaria vaccine by 2028
|
|
Jun 24
|
EMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related Itch
|
|
Jun 24
|
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis
|
|
Jun 23
|
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
|
|
Jun 19
|
FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention
|
|
Jun 18
|
GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?
|
|
Jun 17
|
Here's Why GSK (GSK) is a Strong Momentum Stock
|
|
Jun 17
|
GSK Licenses Shigella Vaccine to Bharat Biotech
|